NurExone Biologic Inc., 2026-03-18
An SEC Form D private-offering notice from Technion City, Haifa, a $279,910 filer-stated offering target in Biotech. Filed 2026-03-18. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Publicly traded biotechnology company, listed as TSXV NRX and OTCQB NRXBF, developing exosome based regenerative therapies for spinal cord injury and other central nervous system conditions.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- SS Innovations International, Inc., 2026-03-19, $18.6M, Gurugram, Haryana
- Metanoia Bio Inc, 2026-03-18, $5M, Lewes, DE
- TOPAS Solutions Inc., 2026-03-18, $1M, Providence, RI
- PIROUETTE PHARMA INC., 2026-03-18, $6M, Portsmouth, NH
- Vesica Health, Inc., 2026-03-17, $4.6M, Irvine, CA
- AgelessRx, Inc., 2026-03-17, Ann Arbor, MI
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.